Pfizer (NYSE:PFE) shares slid 3% after reporting a drop in fourth-quarter revenue, reflecting reduced demand for its Covid-19 vaccine and antiviral treatment. The pharmaceutical company posted a net ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results